Balyasny Asset Management
ELGX

Balyasny Asset Management’s Endologix Inc ELGX Stock Holding History

Balyasny Asset Management’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,066
Closed -$117K – 2246
2018
Q2 		$117K Buy
+2,066
New +$105K ﹤0.01% 1699
2018
Q1 		– Sell
-2,590
Closed -$139K – 2508
2017
Q4 		$139K Buy
+2,590
New +$137K ﹤0.01% 1952

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $8.93B AUM 25.13% 1-Year Est. Return

Balyasny Asset Management's ELGX Position: Q3 2018 in Review

Balyasny Asset Management sold out of Endologix Inc (ELGX) in Q3 2018, closing a stake of 2,066 shares — an estimated $117K sold.

Balyasny Asset Management first reported a position in ELGX in Q4 2017 and held it in 2 quarters. The position peaked at $139K in Q4 2017. 100 funds tracked by Wall St. Rank hold ELGX as of Q3 2018.

  • Balyasny Asset Management reported no remaining Endologix Inc position as of Q3 2018 after selling out during the quarter.
  • Balyasny Asset Management sold 2,066 Endologix Inc shares in Q3 2018, an estimated $117K.
  • Balyasny Asset Management first reported a position in Endologix Inc in Q4 2017 and held it in 2 quarters.
  • Balyasny Asset Management's Endologix Inc position peaked at $139K in Q4 2017.
  • 100 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2018.

Based on Balyasny Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.